Efficacy and Safety of Monotherapy With Mycophenolate Mofetil in Liver Transplantation

Transplantation Proceedings

Volumn 38, Issue 8, 2006, Pages 2480-2481

  Jimenez Perez M ^a   Lozano Rey, J M ^a   Marin Garcia D ^a   Olmedo Martin R ^a   de la Cruz Lombardo, J ^a   Rodrigo Lopez J M ^a  

^a HOSPITAL REGIONAL UNIVERSITARIO DE MÁLAGA   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

CALCINEURIN INHIBITOR; CYCLOSPORIN; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; TSUKUBAENOLIDE;

ADULT; ANEMIA; ARTICLE; BONE MARROW TOXICITY; CHRONIC KIDNEY FAILURE; CLINICAL ARTICLE; CONTROLLED STUDY; CREATININE BLOOD LEVEL; DIABETES MELLITUS; DIARRHEA; DISEASE SEVERITY; DRUG DOSE REDUCTION; DRUG EFFICACY; DRUG SAFETY; FEMALE; FOLLOW UP; GASTROINTESTINAL TOXICITY; HERPES ZOSTER; HUMAN; HYPERTENSION; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY FUNCTION; LIVER GRAFT REJECTION; LIVER TRANSPLANTATION; MALE; MONOTHERAPY; NEUROTOXICITY; PNEUMOCYSTOSIS; PRIORITY JOURNAL; STATISTICAL SIGNIFICANCE;

CREATININE; FOLLOW-UP STUDIES; HUMANS; IMMUNOSUPPRESSIVE AGENTS; KIDNEY FUNCTION TESTS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; MYCOPHENOLIC ACID; RETROSPECTIVE STUDIES; SAFETY; TIME FACTORS;

EID: 33750623857     PISSN: 00411345     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.transproceed.2006.08.039     Document Type: Article

References (12)

1. Hodge E.E., Reich D.J., Clavien P.A., et al. Use of mycophenolate mofetil in liver transplant recipients experiencing renal dysfunction on clyclosporine or tacrolimus-randomized, prospective, multicenter study results. Transplant Proc 34 (2002) 1546
2. Koch R.O., Graziadei I.W., Schulz F., et al. Long-term efficacy and safety of mycophenolate mofetil in liver transplant recipients with calcineurin inhibitor-induced renal dysfunction. Transpl Int 17 (2004) 518
3. Beckebaum S., Cicinnati C.G., Klein E., et al. Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors and graft function in liver transplant patients: preliminary results of an open prospective study. Transplant Proc 36 (2004) 2671
4. Torras J., Figueras J., Lama C., et al. Mycophenolate mofetil overlap in liver transplant recipients with chronic cyclosporine nephrotoxicity. Transplant Proc 31 (1999) 2430
5. Garci{dotless}́a C.E., Ribeiro H.B., Garci{dotless}́a R.L., et al. Mycophenolate mofetil in stable liver transplant patients with calcineurin inhibitor-induced renal impairment: single-center experience. Transplant Proc 35 (2003) 1131
6. Cantarovich M., Tzimas G.N., Barkun J., et al. Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in long-term liver transplant patients with renal dysfunction. Transplantation 76 (2003) 98
7. Moreno-Planas J.M., Cuervas-Mons M.V., Rubio E., et al. Mycophenolate mofetil can be used as monotherapy late alter liver transplantation. Am J Transplant 4 (2004) 1650
8. Fairbanks K., and Thuluvath J. Mycophenolate mofetil monotherapy in liver transplant recipients: a single center experience. Liver Transpl 10 (2004) 1189
9. Raimondo M.L., Dagher L., Papatheodoridis G.V., et al. Long-term mycophenolate mofetil monotherapy in combination with calcineurin inhibitors for chronic renal dysfunction after liver transplantation. Transplantation 75 (2003) 186
10. Schlitt H.J., Barkmann A., Boker K.H., et al. Replacement of calcineurin inhibitors with mycophenolate mofetil in liver-transplant patients with renal dysfunction: a randomized controlled study. Lancet 357 (2001) 587
11. Barkmann A., Nashan B., Schmidt H.H.J., et al. Improvement of acute and chronic renal dysfunction in liver transplant patients after substitution of calcineurin inhibitors by mycophenolate mofetil. Transplantation 69 (2000) 1886
12. Herrero J.I., Quiroga J., Sangro B., et al. Conversión of liver transplant recipients on cyclosporine with renal impairment to mycophenolate mofetil. Liver Transpl Surg 5 (1999) 414